Maureen Quinlan, DPM
Foot Surgery · Columbia, SCNPI 1003013632
Payments from drug & device makers
What this record shows
This record is dominated by other: $44,800 of the $45,853 with a category attached, or 97.7%. Convatec Inc. accounts for 97.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2024 at $44,967 and has fallen 99.8% since, to $70 in 2025. Among foot surgery clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 47 payments — averaging $975.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$45K
- Musculoskeletal Transplant Foundation Inc.$288
- Nevro Corp.$119
- Paratek Pharmaceuticals, Inc.$116
- Smith+Nephew$101
- Stryker$42
- plus $389 from 18 others
What the payments were for
- Food & beverage$1,0532%
- Other$44,80098%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 1 | $44,800 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $288 |
| Nevro Corp. | 6 | $119 |
| Paratek Pharmaceuticals, Inc. | 5 | $116 |
| Smith+Nephew | 5 | $101 |
| Stryker(2 entities) | 2 | $42 |
| AbbVie | 2 | $41 |
| Melinta Therapeutics, LLC | 2 | $34 |
| Cashflow Solutions, LLC | 2 | $31 |
| Sebela Pharmaceuticals Inc. | 2 | $30 |
| GRT US Holding, Inc. | 1 | $30 |
| Merck | 2 | $28 |
| Nabriva Therapeutics, PLC | 2 | $25 |
| Integra Lifesciences Corporation | 1 | $22 |
| Kerecis Limited | 1 | $22 |
| ERMI LLC | 1 | $18 |
| Abbott | 1 | $17 |
| Triad Life Sciences Inc. | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
| Novum Pharma, LLC | 1 | $13 |
| Paragon 28, Inc. | 1 | $11 |
| Zimmer Biomet | 1 | $11 |
| Pacira Pharmaceuticals Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$44,800
How this compares
$45,853 in reported general payments places this provider in the 95th percentile of 28 foot surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 102 | $3,713 |
| Ammonium Lactate | 160 | $3,331 |
| Ketoconazole | 100 | $2,708 |
| Ciclopirox | 17 | $426 |
| Mupirocin | 28 | $200 |
| Gabapentin | 15 | $128 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $74 |
| Cephalexin | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Columbia
- Amanda WarnerColumbia$9K
- Heather DriessenColumbia$3K
- Joseph MoranColumbia$1K
- Ashley NettlesColumbia$246
- Thomas NguyenColumbia$199
- Jordanna BakerFlorence$36K
- Christopher CrabtreeRock Hill$11K
- George SichAiken$6K
- Jeffrey ArmstrongCharleston$4K
- David NegronSpartanburg$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.